Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Granulomatosis with polyangiitis presenting with rare urogenital involvement: a case based review.

Rheumatology international·2026
Same author

Higher Serum Omega-3 Polyunsaturated Fatty Acid Content Is Associated with Improved Long-Term Cardiovascular and Renal Outcomes in Patients with Chronic Kidney Disease.

Nutrients·2026
Same author

From Autoimmune Sialadenitis to Central Pain: Hypothesizing Shared Pathogenesis for Fibromyalgia and Primary Sjogren's Disease and Identifying Essential Screening Strategies.

International journal of molecular sciences·2025
Same author

Association between serum fatty acids and microcirculation in kidney transplant recipients.

Scientific reports·2025
Same author

Distinct characteristics of carpal tunnel syndrome among Sjögren's disease patients and their clinical implications.

Reumatologia·2025
Same author

Underestimated pyridoxine consumption and neurotoxicity: a novel manifestation with rheumatologic relevance - a case-based review.

Rheumatology international·2025
Same journal

Axial gout diagnosed by dual-energy CT in a young normouricaemic man with recurrent nephrolithiasis: a case-based review.

Rheumatology international·2026
Same journal

Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case-control study.

Rheumatology international·2026
Same journal

VEXAS syndrome unmasked from relapsing polychondritis and infection mimicry: a case-based review.

Rheumatology international·2026
Same journal

Myocarditis as the first sign of SLE: a case report and review of the literature.

Rheumatology international·2026
Same journal

Infrared thermography of the tongue in systemic lupus erythematosus: a pilot study of thermal response to cold stimulation.

Rheumatology international·2026
Same journal

Pre-referral laboratory completeness and diagnostic yield in an early arthritis clinic: a retrospective single-centre analysis.

Rheumatology international·2026
查看所有相关文章

相关实验视频

Updated: Jun 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

系统性硬化症中的代谢学.

Zuzanna Gogulska1, Zaneta Smolenska2, Jacek Turyn3

  • 1Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Gdansk, Poland. zuzannagogulska@gumed.edu.pl.

Rheumatology international
|July 9, 2024
PubMed
概括
此摘要是机器生成的。

系统性硬化症诊断需要更好的生物标志物. 代谢学表明有希望,但目前的研究有不一致的发现和糟糕的患者描述,需要进一步的研究.

关键词:
代谢组中的代谢.代谢学 代谢学 代谢学系统性硬化症 系统性硬化症

更多相关视频

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.3K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

512

相关实验视频

Last Updated: Jun 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.3K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

512

科学领域:

  • 自身免疫性疾病是一种自身免疫性疾病.
  • 代谢学 代谢学 代谢学
  • 发现生物标志物的发现.

背景情况:

  • 系统性硬化症是一种罕见的自身免疫性疾病,具有严重的,无法治愈的并发症.
  • 准确和快速的诊断对于患者的生存和生活质量至关重要.
  • 现有的系统性硬化症生物标志物不足以满足临床需求.

研究的目的:

  • 审查和总结现有的对系统性硬化症的代谢学研究.
  • 评估当前的代谢学状态,以识别系统性硬化症生物标志物.
  • 确定局限性,并建议该领域的未来研究方向.

主要方法:

  • 对11项相关的代谢学研究进行了叙述性审查.
  • 分析了研究系统性硬化症患者和对照组的研究.
  • 提取了已识别的代谢物和患者队列描述的数据.

主要成果:

  • 所有审查的研究都报告了系统性硬化症患者和对照人群之间的显著代谢差异.
  • 然而,具体代谢物发现在研究中高度不一致.
  • 大多数研究都缺乏对患者队列的详细描述,并采用了各种包含/排除标准.

结论:

  • 代谢学显示了系统性硬化症生物标志物发现的潜力.
  • 发现的不一致性和方法的异质性限制了当前的应用.
  • 未来的研究需要标准化,细致的患者评估,以可靠地识别生物标志物.